We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Spectrometry Provides Nanoscale View of Biologic World

By Biotechdaily staff writers
Posted on 12 Oct 2006
The development of new multi-isotope imaging mass spectrometry (MIMS) that enables scientists to image and quantify molecules within individual mammalian or bacterial cells has applications in all fields of biology and biomedical research.

"This method allows us to see what has never been seen before, and to measure what has never before been measured,” explained Dr. More...
Claude Lechene, from Harvard Medical School (Boston, MA, USA), who, together with colleagues around the world, developed MIMS.

In this new mass-spectrometry method, a beam of ions is used to bombard the surface atoms of the biologic sample, and a fraction of the atoms are emitted and ionized. These "secondary ions” can then be manipulated with ion optics--in much the same way that lenses and prisms manipulate visible light--to create an atomic mass image of the sample. Dr. Lechene and colleagues developed MIMS by combining the use of a novel secondary-ion mass spectrometer developed by Georges Slodzian, of the Universite Paris-Sud (France), labeling with stable isotopes, and building quantitative image-analysis software.

"Imagine looking into a building, slice by slice. You can see not only that it contains apartments, but also that each apartment contains a refrigerator. You can see there are tomatoes in the refrigerator of one apartment, and potatoes in the refrigerator of another. You can count how many there are and measure how fast they are used and replaced. It is this level of resolution and quantification that MIMS makes possible,” noted Dr. Lechene.

MIMS can generate quantitative, three-dimensional (3D) images of proteins, DNA, RNA, sugar, and fatty acids at a subcellular level in tissue sections or cells. "Using MIMS, we can image and quantify the fate of these molecules when they go into cells, where they go, and how quickly they are replaced,” said Dr. Lechene.

The method does not need staining or the use of radioactive labeling. Instead, it can use stable isotopes to track molecules. MIMS has been used to measure the capture of atmospheric nitrogen and its conversion to dietary nitrogen within single bacteria, a phenomenon essential to supporting life on earth. MIMS may have applications in tracking stem cells and in understanding why some organ transplants are rejected.

The development of MIMS was reported in the October 5, 2006, issue of the Journal of Biology of Biomed Central (http://jbiol.com/content/5/5/20).

"The most significant feature of this technique is that it opens up a whole new world of imaging; we haven't yet imagined all that we can do with it,” observed Dr. Peter Gillespie, of the Oregon Health and Science University (Portland, OR, USA), in an accompanying article in the Journal of Biology.



Related Links:
Harvard Medical School

New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
HPV Test
Allplex HPV28 Detection
New
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.